 D46 |
 |
Myelodysplastic syndromes  |
| |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
| Excludes2 |
drug-induced aplastic anemia (D61.1)
|
|
| |
 D46.0 |
|
Refractory anemia without ring sideroblasts, so stated |
| |
| Refractory anemia without sideroblasts, without excess of blasts |
|
|
| |
| D46.1 |
|
Refractory anemia with ring sideroblasts |
| |
|
|
| |
| D46.2 |
|
Refractory anemia with excess of blasts [RAEB] |
| |
| D46.20 |
|
Refractory anemia with excess of blasts, unspecified |
| |
|
| | |
| D46.21 |
|
Refractory anemia with excess of blasts 1 |
| |
|
| | |
| D46.22 |
|
Refractory anemia with excess of blasts 2 |
| |
|
| |
| |
| D46.A |
|
Refractory cytopenia with multilineage dysplasia |
|
| |
| D46.B |
|
Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| |
|
|
| |
| D46.C |
|
Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
| |
| Myelodysplastic syndrome with 5q deletion | | 5q minus syndrome NOS |
|
|
| |
| D46.4 |
|
Refractory anemia, unspecified |
|
| |
| D46.Z |
|
Other myelodysplastic syndromes |
| |
| Excludes1 |
chronic myelomonocytic leukemia (C93.1-)
|
|
|
| |
| D46.9 |
|
Myelodysplastic syndrome, unspecified |
| |
|
|